| DNA replication |
1.66 |
5.08e-1 |
34/36 (94.44%) |
MCM2;FEN1;RFC2;...
|
| Fatty acid biosynthesis |
1.57 |
6.37e-1 |
16/18 (88.89%) |
FASN;ACSL3;ACACB;...
|
| Glutathione metabolism |
1.52 |
6.71e-1 |
43/57 (75.44%) |
RRM2;GPX3;MGST2;...
|
| Regulation of lipolysis in adipocytes |
1.48 |
6.82e-1 |
52/55 (94.55%) |
MGLL;ADCY1;PTGS2;...
|
| Phenylalanine metabolism |
1.47 |
6.30e-1 |
14/17 (82.35%) |
ALDH3A1;AOC3;MAOA;...
|
| Platelet activation |
1.21 |
6.96e-1 |
106/124 (85.48%) |
SRC;COL1A2;ADCY1;...
|
| Hypertrophic cardiomyopathy |
1.21 |
6.79e-1 |
81/90 (90%) |
DES;ACTC1;ATP2A2;...
|
| Salivary secretion |
1.21 |
6.65e-1 |
76/93 (81.72%) |
ADCY1;ITPR1;GUCY1A1;...
|
| Amoebiasis |
1.20 |
6.49e-1 |
99/102 (97.06%) |
COL1A2;COL4A5;ADCY1;...
|
| Morphine addiction |
1.19 |
6.64e-1 |
80/91 (87.91%) |
ADCY1;PRKCB;GNAS;...
|
| Gap junction |
1.18 |
6.92e-1 |
72/88 (81.82%) |
SRC;PDGFC;ADCY1;...
|
| Protein processing in endoplasmic reticulum |
1.18 |
6.86e-1 |
127/171 (74.27%) |
PDIA3;HSPA1A;HSPA8;...
|
| Folate biosynthesis |
1.18 |
6.73e-1 |
23/26 (88.46%) |
AKR1C3;GGH;AKR1B10;...
|
| Arachidonic acid metabolism |
1.17 |
6.66e-1 |
48/61 (78.69%) |
GPX3;PTGIS;GPX1;...
|
| Estrogen signaling pathway |
1.16 |
7.06e-1 |
119/137 (86.86%) |
KRT19;SRC;ADCY1;...
|
| VEGF signaling pathway |
1.16 |
6.92e-1 |
50/59 (84.75%) |
SRC;PTGS2;PRKCB;...
|
| Chemical carcinogenesis |
1.15 |
6.96e-1 |
186/281 (66.19%) |
SRC;EPHX1;MGST2;...
|
| N-Glycan biosynthesis |
1.15 |
7.01e-1 |
38/50 (76%) |
FUT8;MAN1A2;DDOST;...
|
| Base excision repair |
1.14 |
6.96e-1 |
29/33 (87.88%) |
FEN1;PCNA;NEIL3;...
|
| Steroid biosynthesis |
1.14 |
6.81e-1 |
19/20 (95%) |
NSDHL;DHCR24;SQLE
|
| Progesterone-mediated oocyte maturation |
1.14 |
6.71e-1 |
75/100 (75%) |
STK10;ADCY1;ADCY9;...
|
| Measles |
1.12 |
7.04e-1 |
133/139 (95.68%) |
IRAK1;IL2RB;CDK6;...
|
| Diabetic cardiomyopathy |
1.11 |
7.09e-1 |
162/203 (79.8%) |
COL1A2;GSR;ATP2A2;...
|
| Drug metabolism |
1.11 |
6.95e-1 |
78/151 (51.66%) |
RRM2;CES1;MGST2;...
|
| Non-small cell lung cancer |
1.11 |
6.82e-1 |
70/72 (97.22%) |
CDK6;RET;PRKCB;...
|
| Spinocerebellar ataxia |
1.11 |
6.71e-1 |
128/143 (89.51%) |
ATXN1;KCND3;RELN;...
|
| Nucleotide excision repair |
1.11 |
6.59e-1 |
40/47 (85.11%) |
MNAT1;RFC2;RFC5;...
|
| Taurine and hypotaurine metabolism |
1.10 |
6.65e-1 |
8/11 (72.73%) |
GAD1;ADO;GAD2;...
|
| Thyroid hormone synthesis |
1.09 |
6.89e-1 |
66/75 (88%) |
GPX3;ADCY1;ITPR1;...
|
| Herpes simplex virus 1 infection |
1.09 |
7.06e-1 |
165/498 (33.13%) |
BST2;SRC;IRAK1;...
|
| Arginine biosynthesis |
-1.36 |
3.51e-1 |
17/22 (77.27%) |
GLS;GLUD2;GOT1;...
|
| B cell receptor signaling pathway |
-1.37 |
3.34e-1 |
71/81 (87.65%) |
PPP3CC;LILRA1;RELA;...
|
| NF-kappa B signaling pathway |
-1.37 |
3.43e-1 |
90/104 (86.54%) |
BIRC3;CSNK2B;CXCL3;...
|
| Acute myeloid leukemia |
-1.37 |
3.54e-1 |
66/67 (98.51%) |
RUNX1;KRAS;JUP;...
|
| mTOR signaling pathway |
-1.38 |
3.53e-1 |
114/154 (74.03%) |
MAPK1;DDIT4;FZD3;...
|
| Apoptosis |
-1.40 |
3.19e-1 |
126/168 (75%) |
PMAIP1;GADD45G;CTSL;...
|
| Sphingolipid metabolism |
-1.41 |
3.21e-1 |
32/49 (65.31%) |
GAL3ST1;NEU1;GALC;...
|
| Synthesis and degradation of ketone bodies |
-1.42 |
3.13e-1 |
9/10 (90%) |
HMGCL;OXCT1;HMGCS1;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.42 |
3.11e-1 |
62/70 (88.57%) |
PTPRZ1;ADAM17;JUN;...
|
| Thyroid cancer |
-1.44 |
2.69e-1 |
36/37 (97.3%) |
TFG;GADD45G;TPR;...
|
| AGE-RAGE signaling pathway in diabetic complications |
-1.45 |
2.79e-1 |
97/100 (97%) |
NRAS;ICAM1;EGR1;...
|
| Bile secretion |
-1.45 |
2.83e-1 |
68/90 (75.56%) |
AQP1;ABCB4;SLC10A2;...
|
| Th1 and Th2 cell differentiation |
-1.46 |
2.73e-1 |
80/92 (86.96%) |
JAK1;IL4;PPP3CC;...
|
| Phagosome |
-1.47 |
2.77e-1 |
118/152 (77.63%) |
TUBB1;ITGA2;SCARB1;...
|
| Vasopressin-regulated water reabsorption |
-1.47 |
2.94e-1 |
40/44 (90.91%) |
CREB5;CREB1;DCTN5;...
|
| Malaria |
-1.49 |
2.65e-1 |
44/50 (88%) |
MET;IL1B;THBS1;...
|
| MicroRNAs in cancer |
-1.50 |
2.45e-1 |
146/310 (47.1%) |
MAPK1;ROCK1;CDKN1A;...
|
| Cholesterol metabolism |
-1.54 |
2.07e-1 |
44/50 (88%) |
LPA;LIPC;APOA1;...
|
| SNARE interactions in vesicular transport |
-1.54 |
2.10e-1 |
19/33 (57.58%) |
BET1;STX4;STX1A;...
|
| PPAR signaling pathway |
-1.54 |
2.28e-1 |
66/74 (89.19%) |
ACADL;APOA2;FABP7;...
|
| Salmonella infection |
-1.56 |
2.19e-1 |
198/249 (79.52%) |
HSP90AA1;ACTR3;TXN;...
|
| Alanine, aspartate and glutamate metabolism |
-1.59 |
1.79e-1 |
27/37 (72.97%) |
ALDH4A1;GFPT2;GLS;...
|
| Nitrogen metabolism |
-1.60 |
1.90e-1 |
16/17 (94.12%) |
CA3;GLUD2;GLUD1;...
|
| African trypanosomiasis |
-1.60 |
2.00e-1 |
32/37 (86.49%) |
HPR;IL12B;ICAM1;...
|
| Hematopoietic cell lineage |
-1.61 |
2.33e-1 |
90/99 (90.91%) |
ITGA2;ANPEP;IL7;...
|
| Complement and coagulation cascades |
-1.65 |
1.87e-1 |
76/85 (89.41%) |
C6;F7;C1QB;...
|
| Primary immunodeficiency |
-1.67 |
1.80e-1 |
33/38 (86.84%) |
PTPRC;CD79A;ICOS;...
|
| Nicotinate and nicotinamide metabolism |
-1.71 |
1.47e-1 |
25/35 (71.43%) |
BST1;SIRT5;AOX1;...
|
| TGF-beta signaling pathway |
-1.74 |
1.52e-1 |
81/94 (86.17%) |
PPP2R1A;HAMP;CUL1;...
|
| Proximal tubule bicarbonate reclamation |
-1.76 |
2.26e-1 |
21/23 (91.3%) |
PCK2;GLS2;ATP1B3;...
|
